Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.740
0.00 (0.00%)
At close: Jul 17, 2026, 4:00 PM EDT
1.760
+0.020 (1.15%)
After-hours: Jul 17, 2026, 7:44 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $74.02 million as of July 17, 2026. Its market cap has increased by 38.64% in one year.
Market Cap
74.02M
Enterprise Value
59.80M
1-Year Change
38.64%
Ranking
Category
Stock Price
$1.74
ChartMarket Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $74.02M, an increase of 18.42%. That is a compound annual growth rate of 2.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 74.02M | -19.28% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 78.57M |
| Enlivex | 76.33M |
| Acrivon Therapeutics | 74.90M |
| Alps Group | 74.05M |
| LeonaBio | 73.36M |
| OKYO Pharma | 72.42M |
| Gain Therapeutics | 70.81M |
| MindWalk Holdings | 70.03M |